Price data is not available
Eikon Therapeutics Inc
EIKNNASDAQ
Eikon Therapeutics fell 59.1% from $15.00 to $6.13, behind the S&P 500's +10.7%. Its worst day was Oct 26 (−23.7%), and its low came Oct 30 at $5.31.
Feb 5, 2026 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Eikon Therapeutics closed at its highest level of the year, 8.4% above where the year started.
+3.4% · S&P 500 +0.5%
EPS of $-1.48 beat the $-1.58 estimate on $0.00 revenue.
Story events cover the past 12 months · Times ET
−1.3% · S&P 500 −0.3%
EPS of $-2.46 beat the $-4.07 estimate on $0.00 revenue.
+15.9% · S&P 500 −0.2%
Eikon Therapeutics shares rose 16.2%, while the S&P 500 fell 0.7%.
+16.2%, the year's best day · S&P 500 −0.7%
EPS of $-1.63 missed the $-1.49 estimate on $0.00 revenue.
+7.0% · S&P 500 −0.2%
Eikon Therapeutics closed at its lowest level of the year, 64.6% below where the year started.
−0.7% · S&P 500 −1.8%
Where it ended: a close of $6.13 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-1.63).
Nothing in the past 12 months.
All EIKN dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for EIKN and SPY from Benzinga historical bars. Not investment advice.
